1. Home
  2. EXAS vs HII Comparison

EXAS vs HII Comparison

Compare EXAS & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$102.34

Market Cap

19.3B

Sector

Health Care

ML Signal

HOLD

Logo Huntington Ingalls Industries Inc.

HII

Huntington Ingalls Industries Inc.

HOLD

Current Price

$425.91

Market Cap

16.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
HII
Founded
1995
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
19.3B
16.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EXAS
HII
Price
$102.34
$425.91
Analyst Decision
Buy
Buy
Analyst Count
19
6
Target Price
$81.27
$342.17
AVG Volume (30 Days)
2.3M
625.8K
Earning Date
02-18-2026
02-05-2026
Dividend Yield
N/A
1.30%
EPS Growth
N/A
N/A
EPS
N/A
14.50
Revenue
$3,082,033,000.00
$12,012,000,000.00
Revenue This Year
$19.40
$5.79
Revenue Next Year
$13.51
$5.42
P/E Ratio
N/A
$29.38
Revenue Growth
14.47
2.60
52 Week Low
$38.81
$158.88
52 Week High
$102.66
$427.72

Technical Indicators

Market Signals
Indicator
EXAS
HII
Relative Strength Index (RSI) 83.39 81.86
Support Level $101.51 $401.20
Resistance Level $102.56 $425.12
Average True Range (ATR) 0.32 11.30
MACD -0.61 5.70
Stochastic Oscillator 81.91 95.54

Price Performance

Historical Comparison
EXAS
HII

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About HII Huntington Ingalls Industries Inc.

Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.

Share on Social Networks: